Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
PRCT Analyst Ratings
Strong Buy
10 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PRCT Stock 12 Month Forecast
Average Price Target
$66.00
▲(80.87% Upside)
| Highest Price Target$85.00 | Average Price Target$66.00 | Lowest Price Target$39.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
―
Hold
―
Reiterated
09/16/25
PROCEPT BioRobotics: Hold Rating Amid Declining Stock, Leadership Change, and Growth ChallengesWe've been a harsh critic of Procept BioRobotics for some time. With shares down ~54% YTD, results have been disappointing despite PRCT's ability to 'beat and raise' against its own guidance. With new CEO Larry Wood coming in and taking the helm on Sept. 2nd, we think PRCT has an opportunity to rewrite its narrative. That said, we think there are a number of things that PRCT would need to do in order to win investors back. Valuation is far more approachable today (~5.0x NTM EV/Sales), and we're often asked at what point is the right time to step-in. Valuation alone won't get shares moving higher though. We lay out what we believe is necessary to excite investors again.
TR | OpenAI - 4o
$41→$39
Hold
6.88%
Upside
Reiterated
09/09/25
AI Generated ArticleAI Generated Article
Oppenheimer
$60
Buy
64.43%
Upside
Upgraded
09/02/25
William Blair
―
Buy
―
Reiterated
08/18/25
Morgan Stanley
$68→$62
Buy
69.91%
Upside
Reiterated
08/08/25
Truist Financial
$70→$64
Buy
75.39%
Upside
Reiterated
08/07/25
Leerink Partners
$83
Buy
127.46%
Upside
Reiterated
08/07/25
Wells Fargo
$75→$58
Buy
58.95%
Upside
Reiterated
08/07/25
Piper Sandler
$80→$55
Buy
50.73%
Upside
Reiterated
08/07/25
TD Cowen
$85
Buy
132.94%
Upside
Reiterated
08/06/25
Bank of America Securities
$84
Buy
130.20%
Upside
Reiterated
07/15/25
Stephens
$70
Buy
91.83%
Upside
Initiated
07/09/25
Jefferies
―
Hold
―
Reiterated
05/02/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
―
Hold
―
Reiterated
09/16/25
PROCEPT BioRobotics: Hold Rating Amid Declining Stock, Leadership Change, and Growth ChallengesWe've been a harsh critic of Procept BioRobotics for some time. With shares down ~54% YTD, results have been disappointing despite PRCT's ability to 'beat and raise' against its own guidance. With new CEO Larry Wood coming in and taking the helm on Sept. 2nd, we think PRCT has an opportunity to rewrite its narrative. That said, we think there are a number of things that PRCT would need to do in order to win investors back. Valuation is far more approachable today (~5.0x NTM EV/Sales), and we're often asked at what point is the right time to step-in. Valuation alone won't get shares moving higher though. We lay out what we believe is necessary to excite investors again.
TR | OpenAI - 4o
$41→$39
Hold
6.88%
Upside
Reiterated
09/09/25
AI Generated ArticleAI Generated Article
Oppenheimer
$60
Buy
64.43%
Upside
Upgraded
09/02/25
William Blair
―
Buy
―
Reiterated
08/18/25
Morgan Stanley
$68→$62
Buy
69.91%
Upside
Reiterated
08/08/25
Truist Financial
$70→$64
Buy
75.39%
Upside
Reiterated
08/07/25
Leerink Partners
$83
Buy
127.46%
Upside
Reiterated
08/07/25
Wells Fargo
$75→$58
Buy
58.95%
Upside
Reiterated
08/07/25
Piper Sandler
$80→$55
Buy
50.73%
Upside
Reiterated
08/07/25
TD Cowen
$85
Buy
132.94%
Upside
Reiterated
08/06/25
Bank of America Securities
$84
Buy
130.20%
Upside
Reiterated
07/15/25
Stephens
$70
Buy
91.83%
Upside
Initiated
07/09/25
Jefferies
―
Hold
―
Reiterated
05/02/25
Best Analysts Covering PROCEPT BioRobotics
1 Month
xxx
Success Rate
9/11 ratings generated profit
Average Return
+12.98%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 81.82% of your transactions generating a profit, with an average return of +12.98% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+15.98%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +15.98% per trade.
1 Year
Success Rate
7/13 ratings generated profit
Average Return
+22.97%
reiterated a buy rating 3 months ago
Copying Craig Bijou's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +22.97% per trade.
2 Years
xxx
Success Rate
10/24 ratings generated profit
Average Return
+7.64%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of +7.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PRCT Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
5
5
1
5
6
Buy
9
11
16
19
15
Hold
9
11
17
19
17
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
27
34
43
38
Each month's total comprises the sum of three months' worth of ratings.
PRCT Financial Forecast
PRCT Stock Forecast FAQ
What is PRCT’s average 12-month price target, according to analysts?
Based on analyst ratings, PROCEPT BioRobotics’s 12-month average price target is 66.00.
What is PRCT’s upside potential, based on the analysts’ average price target?
PROCEPT BioRobotics has 80.87% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PRCT a Buy, Sell or Hold?
PROCEPT BioRobotics has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
What is PROCEPT BioRobotics’s price target?
The average price target for PROCEPT BioRobotics is 66.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $85.00 ,the lowest forecast is $39.00. The average price target represents 80.87% Increase from the current price of $36.49.
The highest analyst price target is $85.00 ,the lowest forecast is $39.00. The average price target represents 80.87% Increase from the current price of $36.49.
What do analysts say about PROCEPT BioRobotics?
PROCEPT BioRobotics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of PRCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.